| 產(chǎn)品名稱 |
NBE870/pNB268 [FD29389] |
| 商品貨號(hào) |
B162415 |
| Designations |
NBE870/pNB268 [FD29389] |
| Depositors |
Pfizer, Inc., LH Huang, Pfizer, Inc. |
| U.S. Patent |
|
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Biosafety Level |
1 |
| Vector Information |
Construct size (kb): 9.899999618530273 |
| Applications |
expression vector shuttle vector |
| Comments |
Restriction digests of the clone give the following sizes (kb): EcoRI--7.6, 1.7, 0.9; BamHI--10.2; HindIII--7.4, 2.7. Constructed from a HindIII/EcoRI fragment (3.0 kb) containing XPR2-derived sequence, an MCS, and a terminator region, and from a partial EcoRI fragment (2.5 kb) containing LEU2. |
| Media |
ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
|
| Growth Conditions |
Temperature: 37.0°C |
| References |
Liang H Huang, personal communication
|
| Shipped |
freeze-dried |
| Shipping Information |
Shipped: ?Freeze dried Escherichia coli containing the phagemid. |
